April 2019 Message from the Director
As we find ourselves at the end of Q1, I am already so proud of what NICA has accomplished and am excited to share what we’ve been up to as we enter Q2.
In case you missed it, we SOLD OUT our first meeting! This was an incredible surprise, and we are so grateful to everyone who has invested their time and resources into making this meeting a success! We did secure a limited quantity of additional tickets, so there is still time to secure your spot at this important event today. Registration prices will increase after April 13.
There is still space in the exhibit hall for companies and nonprofit organizations that want to get their products/services in front of over 200 professionals and leaders in the infusion industry! Learn more about exhibiting here.
Welcome, NICA Provider Members!
This quarter, there were 40 new and returning infusion providers that chose to support NICA through provider membership. This is the largest number of provider memberships we’ve issued in a single quarter since starting the program, and we are so grateful to those of you who have entrusted us with protecting your patients’ access to the life-changing infusion/injection care you provide!
As many of you are aware, we’ve been working with members of our Advisory Committee and State Boards of Nursing to establish foundational standards of practice for the administration of intravenous and injectable products in an outpatient setting. These standards are intended to reduce disparities in quality care across outpatient care settings and ensure that patients are protected from potentially harmful practices. These standards will soon be ready for distribution, so sign up here to receive a notification when they are published.
I was honored to be part of the Lupus and Allied Diseases Association (LADA)’s educational symposium, Enhancing Lives by Empowering the Lupus Community, in Hawaii. Hosted by Lupus and Allied Diseases Association, Inc. (LADA) and the Sjogren’s & Lupus Foundation of Hawaii, this was an incredible opportunity to educate and empower patients within the autoimmune community and it was an honor to deliver a presentation on demystifying biologics, infusions, and access to treatment. We applaud LADA’s efforts to facilitate patient-focused educational opportunities and wish them the best as they continue these symposiums in San Francisco, CA and Littleton, CO.
Thank you for being part of the NICA team. Your continued support has contributed to our success, and we wouldn’t be here without you and your patients. As we enter into what promises to be an exciting second quarter, make sure you are following us on Twitter, LinkedIn, Facebook, or Instagram to stay up-to-date with the latest goings on at NICA.
Thank you for your time,
Brian Nyquist, MPH
Executive Director, National Infusion Center Association